24 results
8-K
EX-99.1
MCRB
Seres Therapeutics Inc
9 Jan 24
Regulation FD Disclosure
7:05am
healthcare costs 35,000 deaths per year in US Major burden to society Many high-risk patient populations Allogeneic Hematopoietic stem cell transplant
8-K
EX-99.1
MCRB
Seres Therapeutics Inc
28 Jun 23
Amendments to Articles of Incorporation or Bylaws
8:00am
to society Many high-risk patient populations Declared “one of the Allogeneic HSCT recipients at risk for world’s most urgent bloodstream infections
8-K
EX-99.2
MCRB
Seres Therapeutics Inc
9 May 23
Seres Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
8:16am
healthcare costs 35,000 deaths per year in US Major burden to society Many high-risk patient populations Allogeneic HSCT recipients at risk for bloodstream
PRE 14A
hgn7guf9bff
14 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.1
56rx gclplp
3 Aug 22
Seres Therapeutics Reports Second Quarter 2022 Financial Results and Provides
7:15am
8-K
EX-99.1
cpi7w7fgugc
6 Apr 22
Regulation FD Disclosure
7:00am
8-K
EX-99.1
izvy9rsgqulxfz2bcnaj
10 Nov 21
Seres Therapeutics Reports Third Quarter 2021 Financial Results and Provides
7:07am
8-K
EX-99.1
g89i1c6npdsd alysz
3 Aug 21
Seres Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
7:14am